July 2017 Section H of the Pharmaceutical Schedule Update
|
|
- Ashlee Strickland
- 5 years ago
- Views:
Transcription
1 16 June 2017 July 2017 Section H of the Pharmaceutical Schedule Update The Section H Update summary is provided to DHB hospital pharmacists as a preview of the changes that will be announced in the next Update to Section H of the Pharmaceutical Schedule, and take effect from the beginning of next month. For any questions about these listing changes, or the Pharmaceutical Schedule in general, please contact us at enquiry@pharmac.govt.nz. Pharmaceutical Acetazolamide (Diamox) tab 250 mg Acitretin (Novatretin) cap 10 mg and 25 mg Adult diphtheria and tetanus vaccine (ADT Booster) inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid in 0.5 ml syringe Alfentanil (Hameln) inj 0.5 mg per ml, 2 ml ampoule Amlodipine (Apo-Amlodipine) tab 2.5 mg, 5 mg and 10 mg Amorolfine (MycoNail) nail soln 5%, 5 ml Amoxicillin (Ibiamox) inj 250 mg, 500 mg and 1 g vials Atropine sulphate (Atropt) eye drops 1%, 15 ml Azithromycin tab 250 mg and 500 mg (Apo-Azithromycin), and grans for oral liq 200 mg per 5 ml (40 mg per ml) (Zithromax) Bendamustine hydrochloride (Ribomustin) inj 25 mg vial and 100 mg vial Benzylpenicillin sodium [Penicillin G] (Sandoz) inj 600 mg (1 million units) vial Betahistine dihydrochloride (Vergo 16) new listing inj 25 mg vial (p code ) inj 100 mg vial (p code )
2 tab 16 mg Bupivacaine hydrochloride (Marcain Isobaric) inj 5 mg per ml, 4 ml ampoule Bupivacaine hydrochloride (Marcain) inj 2.5 mg per ml, 100 ml bag Cefazolin (AFT) inj 500 mg vial and 1 g vial Cefotaxime (DBL Cefotaxime) inj 1 g vial Ciprofloxacin (Cipflox) tab 250 mg, 500 mg and 750 mg Clarithromycin (Apo-Clarithromycin) tab 250 mg and 500 mg Clarithromycin (Martindale) inj 500 mg vial Clonidine patch 2.5 mg, 100 mcg per day patch 5 mg, 200 mcg per day patch 7.5 mg, 300 mcg per day Cyproterone acetate with ethinyloestradiol (Ginet) tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets Dexmedetomidine (Precedex) inj 100 mcg per ml, 2 ml vial Diphtheria, tetanus and pertussis vaccine (Boostrix) inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagluttinin and 2.5 mcg pertactin in 0.5 ml syringe Diphtheria, tetanus, pertussis and polio vaccine (Infanrix IPV) inj 30 IU diphtheria Brand change Mylan new listing and patch 2.5 mg, 100 mcg per day (p code ) patch 5 mg, 200 mcg per day (p code ) patch 7.5 mg, 300 mcg per day (p code ) Catapress-TTS-1, Catapress-TTS-2 and Catapress-TTS-3 patches to be delisted 1 September 2017
3 toxoid with 30IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagluttinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5 ml syringe Diphtheria, tetanus, pertussis, polio, hepatitis b and haemophilus influenzae type b vaccine (Infanrix-hexa) inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagluttinin, 8 mcg pertactin, 80 D-antigen units poliomyelitis virus, 10 mcg hepatitis B surface antigen in 0.5 ml syringe (1) and inj 10 mcg haemophilus influenzae type B vaccine vial Docetaxel (DBL Docetaxel) inj 10 mg per ml, 2 ml vial and 8 ml vial Docusate sodium (Coloxyl) tab 50 mg and 120 mg Donepezil hydrochloride (Donepezil-Rex) tab 5 mg and 10 mg Doxazosin (Apo-Doxazosin) tab 2 mg Doxazosin (Apo-Doxazosin) tab 4 mg Ephedrine (Max Health) inj 30 mg per ml, 1 ml ampoule Erlotinib (Tarceva) tab 100 mg and 150 mg Exemestane (Pfizer Exemestane) tab 25 mg Flucloxacillin (Flucloxin) inj 250 mg and 500 mg vials Flucloxacillin inj 1 g vial Gefitinib (Iressa) tab 250 mg price increase and Brand change Flucil new listing and (p code ) Flucloxin to be delisted 1 September 2017
4 Gliclazide (Glizide) tab 80 mg Glycerol liq Haemophilus influenzae type b vaccine (Hiberix) Haemophilus Influenzae type B polysaccharide 10 mcg conjugated to tetanus toxoid as carrier protein mcg; prefilled syringe plus vial 0.5 ml Haemophilus influenzae type b vaccine (Act-HIB) inj 10 mcg vial with diluent syringe Hepatitis A vaccine inj 720 ELISA units in 0.5 ml syringe (Havrix Junior) and inj 1440 ELISA units in 1 ml syringe (Havrix) Hepatitis B recombinant vaccine (HBvaxPRO) inj 5 mcg in 0.5 ml vial and inj 10 mcg in 1 ml vial Hepatitis B recombinant vaccine (HBvaxPRO) inj 40 mcg in 1 ml vial Hydrocortisone (ABM) powder Hydrocortisone and paraffin liquid and lanolin (DP Lotn HC) lotn 1% with paraffin liquid 15.9% and lanolin 0.6% Infliximab (Remicade) inj 100 mg Influenza vaccine (Influvac) inj 45 mcg in 0.5 ml syringe Iodised oil (Lipiodol Ultra Fluid) inj 38% w/w (480 mg per ml), 10 ml ampoule Isosorbide mononitrate (Duride) tab longacting 60 mg Ivabradine tab 5 mg Ketoconazole (Sebizole) shampoo 2%, Brand change healthe Glycerol BP Liquid, 500 ml new listing and (p code ) ABM, 2,000 ml to be delisted 1 September 2017 new listing and (p code ) to be delisted 1 October 2017 and price increase new presentation listing
5 100 ml Lamivudine (Zeffix) tab 100 mg and oral liq 5 mg per ml Lenalidomide (Revlimid) cap 15 mg new listing (p code ) Lidocaine [lignocaine] (LMX4) crm 4%, 5 g tubes Lidocaine [lignocaine] hydrochloride with adrenaline and tetracaine hydrochloride (Topicaine) soln 4% with adrenaline 0.1% and tetracaine hydrochloride 0.5%, 5 ml syringe Lopinavir with ritonavir (Kaletra) tab 200 mg with ritonavir 50 mg Magnesium sulphate (DBL) inj 2 mmol per ml, 5 ml ampoule Measles, mumps and rubella vaccine (Priorix) injection, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml Measles, mumps and rubella vaccine (M- M-R-II) inj 1000 TCID50 measles, TCID50 mumps and 1000 TCID50 rubella vial with diluent Pack size change 5 g tube new listing (p code ) 5 x 5 g tubes to be delisted 1 December 2017 new listing and (p code ) to be delisted 1 October 2017 Melatonin Circadin tab modified-release 2 mg new listing (p code ) tab 3 mg note added tab 1 mg and 2 mg to be delisted 1 January 2018 cap 2 mg and 3 mg to be delisted 1 January 2018 Meningococcal (A, C, Y and W-135) conjugate vaccine (Menactra) inj 4 mcg or each meningococcal polysaccharide conjugated to a total of approximately 48 mcg of diphtheria toxoid carrier per 0.5 ml vial
6 Meningococcal C conjugate vaccine (Neisvac-C) inj 10 mcg in 0.5 ml syringe, Methotrexate (Methotrexate Ebewe) inj 100 mg per ml, 50 ml vial Miconazole nitrate (Micreme) vaginal crm 2% with applicator, 40 g Morphine sulphate (Sevredol) tab immediate-release 10 mg and 20 mg Morphine sulphate (DBL Morphine Sulphate) inj 5 mg per ml, 1 ml ampoule; 10 mg per ml, 1 ml ampoule; 15 mg per ml, 1 ml ampoule; and 30 mg per ml, 1 ml ampoule Naltrexone hydrochloride (Naltraccord) tab 50 mg Nivolumab (Opdivo) inj 10 mg per ml, 4 ml vial and 10 ml vial Non-nucleoside reverse transcriptase inhibitors Noradrenaline (Noradrenaline BNM) inj 1 mg per ml, 4 ml ampoule Nucleoside reverse transcriptase inhibitors Olanzapine tab 2.5 mg, 5 mg and 10 mg (Zypine) and tab orodispersible 5 mg and 10 mg (Zypine ODT) Olopatadine (Patanol) eye drops 0.1%, 5 ml Oxazepam (Ox-Pam) tab 10 mg and 15 mg Paracetamol (Perfalgan) inj 10 mg per ml, 50 ml vial Paracetamol inj 10 mg per ml, 100 ml vial Pack size change 1 injection pack 10 injection pack to be delisted 1 July 2017 new listing and (p code ) price decrease to be delisted 1 September 2017 Brand change Paracetamol Kabi new listing and addition
7 of HSS (p code ) Perfalgan to be delisted 1 September 2017 Paracetamol with codeine (Paracetamol + Codeine (Relieve)) tab paracetamol 500 mg with codeine phosphate 8 mg, 1,000 tab pack Pamidronate disodium (Pamisol) inj 3 mg per ml, 10 ml vial and 9 mg per ml, 10 ml vial Pamidronate disodium (Pamisol) inj 6 mg per ml, 10 ml vial Pembrolizumab (Keytruda) inj 50 mg vial Perindopril (Apo-Perindopril) tab 2 mg and 4 mg Pethidine hydrochloride (DBL Pethidine Hydrochloride) inj 50 mg per ml, 1 ml and 2 ml ampoules Pneumococcal (PCV10) conjugated vaccine (Synflorix) inj 1 mcg of pneumococcal polysaccharide serotypes 1, 5, 6B, 7F, 9V, 14 and 23F; 3 mcg of pneumococcal polysaccharide serotypes 4, 18C and 19F in 0.5 ml prefilled syringe Pneumococcal (PCV13) conjugate vaccine (Prevenar 13) inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5 ml syringe Pneumococcal (PPV23) polysaccharide vaccine (Pneumovax 23) inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype) Poliomyelitis vaccine (IPOL) inj 80 D- antigen units in 0.5 ml syringe Poloxamer (Coloxyl) oral drops 10%, 30 ml Pack size change 1,000 tab pack and (p code ) 100 tab pack to be delisted 1 September 2017 price increase and new listing and (p code ) amended presentation description and restriction and
8 Procaine penicillin (Cilicaine) inj 1.5 g in 3.4 ml syringe Protease inhibitors Quetiapine (Quetapel) tab 25 mg, 100 mg, 200 mg and 300 mg Rifampicin (Rifadin) cap 150 mg and 300 mg, oral liq 100 mg per 5 ml, and inj 600 mg vial Rifaximin (Xifaxan) tab 550 mg Rituximab (Mabthera) inj 10 mg per ml, 10 ml vial and 50 ml vial Rizatriptan (Rizamelt) tab orodispersible 10 mg Ropivacaine hydrochloride inj 2 mg per ml, 100 ml and 200 ml bags Ropivacaine hydrochloride (Ropivacaine Kabi) inj 2 mg per ml, 10 ml and 20 ml ampoules; inj 7.5 mg per ml, 10 ml and 20 ml ampoules; and inj 10 mg per ml, 10 ml and 20 ml ampoules Rotavirus oral vaccine (Rotarix) oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator Rotavirus live reassortant oral vaccine (RotaTeq) oral susp G1, G2, G3, G4, P1(8) 11.5 million CCID50 units per 2 ml, tube Roxithromycin (Rulide D) tab dispersible 50 mg Sildenafil inj 0.8 mg per ml, 12.5 ml vial Sodium citro-tartrate (Ural) grans eff 4 g Brand change Ropivacaine Kabi new listing and addition of HSS 100 ml bag (p code ) 200 ml bag (p code ) Naropin 100 ml and 200 ml bags to be delisted 1 September 2017 new listing and (p code ) to be delisted 1 October 2017 new listing (p code ) new listing and
9 sachets Strand transfer inhibitors Temazepam (Normison) tab 10 mg Testosterone cypionate (Depo- Testosterone) inj 100 mg per ml, 10 ml vial Timolol (Arrow-Timolol) eye drops 0.25% and 0.5%, 5 ml Tramadol hydrochloride tab sustained-release 100 mg (Tramal SR 100) tab sustained-release 150 mg (Tramal SR 150) tab sustained-release 200 mg (Tramal SR 200) Tramadol hydrochloride (Arrow-Tramadol) cap 50 mg Tramadol hydrochloride inj 50 mg per ml, 1 ml ampoule (Tramal 50) and 2 ml ampoule (Tramal 100) Triamcinolone acetonide (Aristocort) crm 0.02%, 100 g Triamcinolone acetonide (Aristocort) oint 0.02%, 100 g Triamcinolone acetonide (Kenacort-A 10) inj 10 mg per ml, 1 ml ampoule Triamcinolone acetonide (Kenacort-A 40) inj 40 mg per ml, 1 ml ampoule Triamcinolone acetonide (Kenalog in Orabase) paste 0.1%, 5 g Tuberculin PPD [mantoux] test (Tubersol) inj 5 TU per 0.1 ml, 1 ml vial Tuberculin, purified protein derivative inj 5 TU per 0.1 ml, 1 ml vial new listing and (p code ) to be delisted 1 July 2017
10 Ursodeoxycholic acid (Ursosan) cap 250 mg Vancomycin (Mylan) inj 500 mg vial Varicella vaccine [chickenpox vaccine] (Varilrix) inj 2000 PFU prefilled syringe plus vial Voriconazole (Vfend) inj 200 mg vial Zidovudine [AZT] with lamivudine (Alphapharm) tab 300 mg with lamivudine 150 mg new listing of 10 vial pack (p code ) amended chemical name and presentation description price increase
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes
30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
More informationChanges to the National Immunisation Schedule
17 December 2013 Changes to the National Immunisation Schedule PHARMAC is pleased to announce decisions related to the National Immunisation Schedule (NIS) that will take effect from 1 July 2014. This
More informationSection H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Management Agency Pharmaceuticals Update Update effective 1 August 2014 New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014
30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014
30 April 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and
More informationRelease of the 2013/14 Invitation to Tender
07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive
More informationPHARMAC invites proposals for the supply of various vaccines in New Zealand.
15 February 2016 Dear Supplier REQUEST FOR PROPOSALS SUPPLY OF VARIOUS VACCINES PHARMAC invites proposals for the supply of various vaccines in New Zealand. This request for proposals (RFP) letter incorporates
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014
28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 April 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, d 3 November
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 September 2017
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2017 Contents Summary of PHARMAC decisions effective 1 September 2017... 3 New listings... 5 Temozolomide
More informationBabyJabs Vaccines. All vaccines are mercury- free We use aluminium- free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury- free We use aluminium- free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
More informationBabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
More informationApproval / Acknowledgement Letter Ref No. / Diary no F.No.12-48/GSK/PAC- Synflorix/15-BD 25-Mar-15 2 GlaxoSmithKline Pharmaceuticals Limited.
1 GlaxoSmithKline Deletion of a n-significant in-process test limit during the purification process of the tetanus / diphtheria toxoids used in the manufacture of GSK's PCV vaccine [brand name: Synflorix]
More informationBabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible
BabyJabs Vaccines All vaccines are mercury-free We use aluminium-free vaccines wherever possible BabyJabs is a dedicated children s immunisation service, offering a choice of single and small combination
More informationNational Immunisation News
July 2015 National Immunisation News The newsletter of the HSE National Immunisation Office CONTENTS Changes to the Primary Childhood Immunisation Programme BCG Shortage Pertussis Vaccine Mumps Order Vaccines
More informationVaccine ingredients. Fact sheet August 2017 page 1. Continued...
Vaccine manufacture and composition is complex and tightly regulated to maximise safety. The safety of the individual components, and of the vaccine itself, must be demonstrated before a vaccine can be
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014
31 October 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2015 Cumulative for May, June and July 2015 Contents Summary of PHARMAC decisions effective 1 July 2015... 3
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
More informationDecision to amend access criteria for some vaccines
3 July 2015 Decision to amend access criteria for some vaccines PHARMAC is pleased to announce the following changes to the funding access criteria for a number of vaccines. The changes in criteria follow
More informationNational Immunisation News The newsletter of the HSE National Immunisation Office
February 2015 National Immunisation News The newsletter of the HSE National Immunisation Office CONTENTS Changes to the PCI programme Uptake statistics Pneumovax name change Flu season Common queries School
More informationTRICARE Retail Vaccination Program Vaccine List - September 2018*
Diphtheria, tetanus and pertussis Diphtheria and tetanus toxoids adsorbed acellular pertussis adsorbed DT DTaP Diphtheria and tetanus toxoids adsorbed Daptacel, Infanrix Tetanus and diphtheria toxoids
More informationSection H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 May 2014 New Zealand Cumulative for April and May 2014 Pharmaceutical
More informationDetailed cost of vaccination/ Immunization in India (Birth to 10 years of age)
Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age) Glossary: IPV= Injectable Polio vaccine OPV= Oral polio vaccine (these are oral drops, which is also given in "Pulse Polio
More informationSection H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 June 2014 New Zealand Cumulative for April, May and June 2014 Pharmaceutical
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table of standardized
More informationPharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 August 2018
Pharmaceutical Management Agency Section H Update for Hospital Pharmaceuticals Effective 1 August 2018 Contents Summary of decisions effective 1 August 2018... 3 Section H changes to Part II... 8 Index...
More information(price) Underlined indicates tender winning product now available at new subsidy $5.62 $4.89. $2.35 (Manuf price $5.26) $2.59
Sole Supply - Pending Changes Quick Reference 1 *** Sorted by Sole *** Chemical Type, Strength, Pack Size Pharmacode Current New Tender of New of Sole Supply and Reference Start Thiamine hydrochloride
More informationNational Immunisation News
National Immunisation News The newsletter of the HSE National Immunisation Office July 2016 Changes to the Primary Childhood Immunisation Programme The National Immunisation Advisory Committee (NIAC) has
More informationEnhanced immunisation schedule Victoria
Children from March 2016 Age Disease Vaccine brand Birth Hepatitis B H-B-Vax-II Paediatric 2 months - from 6 weeks Diphtheria-tetanus-pertussis, poliomyelitis-hepatitis B- Reconstitute Site given Route
More informationImmunise your child on time. It s their best protection
Immunise your child on time It s their best protection If you are a parent or caregiver, this pamphlet is for you. It tells you about the recommended ages for your baby to receive their immunisations.
More informationPrice Changes advised by Pharmac As at 12 June 2015
s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule % + or - 01 Jun 15 31 Oct
More informationAdvisory Committee on Immunization Practices VACCINE ACRONYMS
May 1, 2015 Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table
More informationimmunisation in New Zealand
This appendix details the history of. Section A1.1 is a brief summary of when each vaccine was introduced to the National Immunisation Schedule (the Schedule). This summary includes vaccines which were
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More informationModern Drug House.
+91-8048941768 Modern Drug House https://www.moderndrughouse.in/ We are one of the leading suppliers and traders of a wide range of Vaccine and Pharmaceutical Products. Owing to its effectiveness, purity
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2014 Contents Summary of PHARMAC decisions effective 1 September 2014... 3 Erythropoietin changes to subsidy...
More informationNotification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
29 February 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2014/15 Invitation to Tender, d 6 November 2014, and
More informationPREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.
An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation
More informationAspirin. Iron Supplements
Interim Final Rules for Non-Grandfathered Group Health Plans and Health Insurance Issuers Coverage of Preventive Services Under the Patient Protection and Affordable Care Act Aspirin Aspirin to Prevent
More informationPHARMAC invites proposals for the supply of various vaccines in New Zealand.
28 June 2013 Dear Supplier REQUEST FOR PROPOSALS SUPPLY OF VARIOUS VACCINES PHARMAC invites proposals for the supply of various vaccines in New Zealand. This request for proposals (RFP) letter incorporates
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 19 December 2014
19 December 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012
More informationImmunisation Policy. Country Children s Early Learning Ph: M:
Immunisation Policy Published June 2018 Review Date December 2019 Sources Education and Care Services National Regulations, October 2017 Guide to the Education and Care Services National Law and the Education
More informationSyrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation
Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation Background Information Immunisation services in Syria Syria had good immunisation services,
More informationVaccine Label Examples
Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Abiraterone acetate (Zytiga) new listing... 5 Actavis
More informationYour DISPENSARY Tips as at 11 March 2016
This information has been prepared to provided some essential buying tips for the upcoming months. It is designed to be used in conjunction with the full text documents contained within the Pharmac Updates
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 February 2018 Cumulative for January and February 2018
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February Cumulative for January and February Contents Summary of PHARMAC decisions effective 1 February... 3 New
More information14: Immunological products and vaccines
File name: Immunological Products and s Formulary BNF Original Date of issue: 30/10/2005 Last Reviewed: 23/11/2012 Version:4 Page 1 of 6 14: Immunological products and vaccines 14.1 Active immunity Live
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February Cumulative for December 2014 and January Contents Summary of PHARMAC decisions effective 1 February... 3
More informationHealthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
More informationVaccination Decision Making: What Providers Need to Know
Objectives Vaccination Decision Making: What Providers Need to Know Kelli Smith, RN, BSN Iowa Department of Public Health Immunization Program Catch-up Schedule: how to most efficiently bring persons up-to-date
More informationRelease of the 2017/18 Invitation to Tender
2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s
More informationImmunisation schedule Victoria
Infants and children July 2018 Birth H-B-Vax-II Paediatric or Paediatric 2 months (from 6 weeks) and 4 months Diphtheria-tetanus-pertussis, poliomyelitis-hepatitis B- Haemophilus influenzae type b Anterolateral
More informationCoverage of Vaccines Medicaid and Child Health Plus Members
Coverage of Vaccines Medicaid and Child Health Plus Members For children between the ages 0-18, routine recommended vaccinations are covered through Vaccines for Children program [VFC]. Fidelis Care will
More informationUpdate New Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2017 Cumulative for September, October, November and December 2017 Contents Summary of PHARMAC decisions
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 4 What s changing?... 6 Metoprolol succinate
More informationGENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES
GENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES DTaP: Diphtheria, Tetanus, acellular Pertussis Vaccine Infanrix Licensed in 1997
More informationSTANWOOD-CAMANO SCHOOL DISTRICT REQUEST FOR PART-TIME ATTENDANCE OR ANCILLARY SERVICES FROM PRIVATE SCHOOL PUPIL
STANWOOD-CAMANO SCHOOL DISTRICT REQUEST FOR PART-TIME ATTENDANCE OR ANCILLARY SERVICES FROM PRIVATE SCHOOL PUPIL 114 F2 Students Please complete ALL information: Name of Pupil Grade Address of Pupil City
More informationVaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
More information2007/08 Tender. Current Subsidy and price. Bendrofluazide Tab 5 mg; 500 tablets, bottle $21.50 $11.75 Arrow-Bendrofluazide (Arrow)
31 March 2010 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Status for some of the products included in the
More informationWhat DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
More informationRelease of the 2014/15 Invitation to Tender
6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until
More informationPrice Changes advised by Pharmac As at 02 July 2015
s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule 01 Jul 15 29 May 15 Irinotecan
More information1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector
1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share
More informationObjectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015
Childhood Immunization Risk of Non-Vaccinated Children Bertha P. Rojas, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital Objectives Understand the definition of herd immunity Identify vaccine-preventable
More informationM I C R O B I O L O G Y
ninth edition TORTORA FUNKE CASE M I C R O B I O L O G Y a n i n t r o d u c t i o n 18 Practical Applications of Immunology PowerPoint Lecture Slide Presentation prepared by Christine L. Case Vaccine
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 August 2014 Cumulative for May, June, July, and August 2014 Contents Summary of PHARMAC decisions effective 1 August
More informationCHILDHOOD VACCINATION
EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016 Contents Summary of PHARMAC decisions effective
More informationCommunicable Disease & Immunization
Communicable Disease & Immunization Ingham County Health Surveillance Book 2016 Communicable Disease & Immunization - 1 Communicable Disease & Immunization T he control of communicable disease and immunization,
More informationIMMUNISATION OF CHILDREN DURING and AFTER CANCER THERAPY
NATIONAL GUIDELINES PAEDIATRIC ONCOLOGY AND HAEMATOLOGY For the Care of Childhood Cancer in Specialist Child Cancer and Shared Care Centres. IMMUNISATION OF CHILDREN DURING and AFTER CANCER THERAPY Date
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018 Contents Summary of PHARMAC decisions effective 1 July 2018... 4
More informationPost-Transplant Vaccination and Re-Immunisation Procedure
Post-Transplant Vaccination and Re-Immunisation Procedure Table of Contents Purpose... 1 Scope/Audience... 1 Associated documents and forms... 1 Definitions... 2 Background... 2 Vaccination Recommendations...
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2015 Cumulative for September, October and November 2015 Contents Summary of PHARMAC decisions effective
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 September 2016
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2016 Contents Summary of PHARMAC decisions effective 1 September 2016... 3 What s changing?... 5 Pembrolizumab
More informationAll Kindergarteners and 4-6 year old transfer students. 4 doses DTP or DTaP 1 dose must be at or after 4 years of age. None
Parents Vaccines Required for School Entry in Michigan Whenever children are brought into group settings, there is a chance for diseases to spread. Children must follow state vaccine laws in order to attend
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 May 2018
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 New tender listings for 1 May... 4 New listings...
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March Cumulative for January, February and March Contents Summary of PHARMAC decisions effective 1 March... 3 What
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2015 Cumulative for September and October 2015 Contents Summary of PHARMAC decisions effective 1 October
More informationState of Alaska Child Care & School Immunization Requirements Packet Revised 08/2010
State of Alaska Child Care & School Immunization Requirements Packet Revised 08/2010 ALASKA IMMUNIZATION PROGRAM (907) 269-8000 OR 1-888-430-4321 http://www.epi.hss.state.ak.us/id/immune.stm (This page
More informationUpdate New Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April Cumulative for January, February, March and April Contents Summary of PHARMAC decisions effective 1 April...
More information2016 Vaccine Preventable Disease Summary
2016 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared October 2017 2016 Summary of Vaccine Preventable Diseases (VPDs) Reported to Ottawa County
More informationImmunization Guidelines For the Use of State Supplied Vaccine July 1, 2011
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationVACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
More informationUpdate. New Zealand Pharmaceutical Schedule. Effective 1 November Cumulative for September, October and November 2018
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2018 Cumulative for September, October and November 2018 Contents Summary of PHARMAC decisions effective
More informationVaccinology 101 for Fellows
Vaccinology 101 for Fellows Meg Fisher, MD Medical Director, The Children s Hospital Monmouth Medical Center An affiliate of the Saint Barnabas Health Care System Long Branch, NJ Disclosures I have no
More information2018/19 Immunisation programmes list of additional and enhanced services
2018/19 Immunisation programmes list of additional and enhanced services 2018/19 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2018 Prepared
More informationHexavalent Vaccines: Hepatitis B antibody response and co-administration with other vaccines
Viral Hepatitis Prevention Board Hanoi, 25 26 July 2018 Hexavalent Vaccines: Hepatitis B antibody response and co-administration with other vaccines Prof. Timo Vesikari Vaccine Research Center University
More informationUpdate New Zealand Pharmaceutical Schedule Effective 1 May 2016
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Sumatriptan update on Sumatriptan injections... 4
More informationApproval of proposals for various pharmaceuticals
9 August 2010 Approval of proposals for various pharmaceuticals PHARMAC is pleased to announce the approval of proposals for pharmaceuticals in several therapeutic groups which aim to address some issues
More informationNational Immunisation News The Newsletter of the HSE National Immunisation Office
August 2017 1 National Immunisation News The Newsletter of the HSE National Immunisation Office CONTENTS Increase in MenC disease Measles outbreak in Europe Increase HPV Vaccine uptake to protect girls
More informationNew Zealand Pharmaceutical Schedule
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2014 Cumulative for September and October 2014 Contents Summary of PHARMAC decisions effective 1 October
More informationImmunisation Subcommittee of PTAC Meeting held 23 May (minutes for web publishing)
Immunisation Subcommittee of PTAC Meeting held 23 May 2016 (minutes for web publishing) Immunisation Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and
More informationA Review of the Pediatric Immunization Schedule
A Review of the Pediatric Immunization Schedule Michaela Christian PGY-1 Pharmacy Practice Resident Mercy Hospital, A Campus of Plantation General Hospital Michaela.Christian@Hcahealthcare.com Objectives
More informationNational Immunisation NEWS The newsletter of the National Immunisation Office Directorate of Population Health
Page 1 of 8 National Immunisation News February 2008 National Immunisation NEWS The newsletter of the National Immunisation Office Directorate of Population Health 2008: Issue 5 HSE National Cold Chain
More informationNational Immunisation News
DN DN W DN C DW DSC DSW DSE DS August 2018 National Immunisation News The Newsletter of the HSE National Immunisation Office Contents Vaccine uptake Changes to the Immunisation Guidelines for Ireland Vaccines
More information